Collectively, our findings highlight the existence of an epistatic β-Catenin/TIC/G-CSF/PMN-MDSCs axis, arguing for its potential actionability for therapeutic intervention to restore an efficient anti-tumor immune response. This evidence concerns the gene CSF3 and neoplasm.